サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：プラスミドDNA製造市場：成長、将来展望、競合分析、2023年～2031年
市場調査レポート
商品コード
1422166

プラスミドDNA製造市場：成長、将来展望、競合分析、2023年～2031年

Plasmid DNA Manufacturing Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 111 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
プラスミドDNA製造市場：成長、将来展望、競合分析、2023年～2031年
出版日: 2024年01月24日
発行: Acute Market Reports
ページ情報: 英文 111 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

プラスミドDNA製造市場の特徴は、様々な治療用途に使用されるプラスミドDNAの生産において重要な役割を果たすことです。プラスミドDNA製造市場は、2024年から2032年の予測期間中にCAGR21％で成長すると予測されています。主要企業が採用する継続的な推進力と革新的な戦略は、プラスミドDNA製造の展望を形成し、高度な遺伝子治療と個別化医療ソリューションの開発に貢献すると予想されます。

遺伝子治療の進歩：プラスミドDNA応用における先駆的イノベーション

プラスミドDNA製造市場は、プラスミドDNAアプリケーションの先駆的イノベーションに代表される遺伝子治療の絶え間ない進歩によって推進されています。その証拠に、様々な遺伝性疾患や慢性疾患を標的とした最先端の遺伝子治療においてプラスミドDNAの統合が成功しています。この原動力は、プラスミドDNAが新規治療法の開発において極めて重要な役割を果たしている、遺伝子ベースの治療法の展望の拡大によって強調されています。プラスミドDNAをベースとした治療法の臨床試験件数や承認件数の増加からも明らかなように、この促進要因は2023年から2032年にかけて市場の成長に大きく寄与すると予想されます。

バイオ医薬品研究開発への投資の増加：高品質プラスミドDNAの需要を後押し

プラスミドDNA製造市場は、バイオ医薬品の研究開発（R&D）への投資の増加により力強い成長を遂げています。その証拠に、バイオ医薬品分野での資金調達や共同研究が増加し、前臨床試験や臨床試験用の高品質プラスミドDNAの需要が急増しています。この原動力は、遺伝子治療、ワクチン、その他のバイオ医薬品の開発におけるプラスミドDNAの極めて重要な役割によって強調されています。研究開発活動やパートナーシップの大幅な増加からも明らかなように、バイオ医薬品イノベーションへの持続的な投資により、市場は大きな恩恵を受ける態勢が整っています。

個別化医療の重視の高まり：標的治療のためのカスタマイズされたプラスミドDNAソリューション

プラスミドDNA製造市場は、個別化医療の重視の高まりによるパラダイムシフトを目の当たりにしています。その証拠に、治療的介入を個々の患者のプロファイルに合わせて調整することへの注目が高まっており、カスタマイズされたプラスミドDNAソリューションの生産が必要とされています。この原動力は、精密医療におけるプラスミドDNAの応用拡大によって強調され、有効性と安全性のプロファイルを強化した標的療法の開発を可能にします。個別化医療への関心の高まりが示すように、プラスミドDNA製造の需要は急増し、個別化治療戦略の特定の要件に対応することが予想されます。

規制上の課題とコンプライアンス：複雑な規制状況への対応

プラスミドDNA製造市場における大きな抑制要因は、規制上の課題とコンプライアンスの問題です。その証拠に、治療用プラスミドDNAの生産と品質管理に関する厳しい規制があります。規制当局が設定したガイドラインを確実に遵守し、メーカーが複雑な規制状況を乗り切る必要があることが、この抑制要因をさらに際立たせています。その証拠に、規制の不確実性やコンプライアンス基準の新興が市場関係者に課題をもたらし、製品開発のペースや市場浸透に影響を与えている例もあります。この制約を克服するには、強固な品質管理システムを確立し、進化する規制要件に遅れを取らないという積極的なアプローチが必要です。

グレード別：プラスミドDNA製造市場が市場を独占

2023年、プラスミドDNA製造市場はGMPグレードセグメントから大きな収益を上げており、これは厳格なGMP基準を満たすプラスミドDNAの需要を反映しています。同時に、2024年から2032年までの予測期間中、最もCAGRが高かったのはR&Dグレードセグメントであり、高品質のプラスミドDNAを必要とする研究活動に重点が置かれていることを示しています。この微妙なセグメンテーションは、異なるグレードにおけるプラスミドDNAの多様な用途を反映しており、それぞれが特定の業界要件や品質基準に対応しています。

開発段階別：プラスミドDNA製造市場が市場を独占

プラスミドDNA製造市場は、2023年に臨床治療薬セグメントからの顕著な収益を示し、臨床段階の治療を進める上でプラスミドDNAが極めて重要な役割を果たしていることを強調しています。同時に、予測期間中に最も高いCAGRを記録したのは、研究開発活動の急増を示す前臨床治療薬セグメントでした。この包括的なセグメンテーションは、さまざまな開発段階におけるプラスミドDNAアプリケーションのダイナミックな性質を示しており、各段階が市場全体の成長に独自に寄与しています。

北米が世界のリーダーであり続ける

2023年のプラスミドDNA製造市場は、地理的に多様な動向を示しましたが、売上高とCAGRでは北米がトップでした。これは、同地域のバイオ医薬品研究開発における優位性と、革新的な遺伝子治療イニシアチブの拠点としての役割を反映しています。堅調なバイオテクノロジーの状況と個別化医療への投資の増加により、欧州も収益に大きく貢献しました。アジア太平洋は新興地域ですが、共同研究の増加やバイオ医薬品の進歩への関心の高まりに後押しされ、プラスミドDNA製造に対する安定した需要を維持しています。これらの地理的動向は、プラスミドDNA製造市場の世界な性質を強調するものであり、さまざまな地域がその拡大と進化において重要な役割を果たしています。

予測期間中に激化する市場競合

競合情勢では、Lonza Group、Fujifilm Holdings Corporation、Aldevron LLC、Charles River Laboratories、VGXI, Inc.、Danaher（Aldevron）、Kaneka Corp.、Nature Technology、Cell and Gene Therapy Catapult、Eurofins Genomics、Luminous BioSciences, LLC、Akron Biotechなどの主要企業が、豊富な専門知識と戦略的アプローチで市場を形成しています。これらの主要企業は、2023年に大幅な売上高を計上し、2024年から2032年まで継続的な成長が見込まれています。遺伝子治療の進化するニーズに対応し、生産能力を拡大し、規制状況へのコンプライアンスを確保することに戦略的に重点を置くことで、これらの企業はプラスミドDNA製造の展望において影響力のある存在として位置づけられています。市場の進展に伴い、これらのプレーヤーは技術の進歩において極めて重要な役割を果たし、治療用途の高品質プラスミドDNAのシームレスな生産に貢献すると予想されます。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 プラスミドDNA製造市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2023 vs 2032

第4章 プラスミドDNA製造市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のプラスミドDNA製造市場金額、2022年～2032年
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーパワー
    • バイヤーパワー
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 経済情勢
    • テクノロジーの情勢
    • 法的情勢
    • 社会的情勢

第5章 プラスミドDNA製造市場：グレード別、2022年～2032年

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • ボリュームと価格の分析、2022年～2032年
  • 市場セグメンテーション
    • 研究開発グレード
    • GMPグレード

第6章 プラスミドDNA製造市場：開発フェーズ別、2022年～2032年

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • ボリュームと価格の分析、2022年～2032年
  • 市場セグメンテーション
    • 前臨床療法
    • 臨床治療学
    • 市販の治療薬

第7章 プラスミドDNA製造市場：用途別、2022年～2032年

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • ボリュームと価格の分析、2022年～2032年
  • 市場セグメンテーション
    • DNAワクチン
    • 細胞・遺伝子治療
    • 免疫療法
    • その他

第8章 プラスミドDNA製造市場：疾患別、2022年～2032年

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • ボリュームと価格の分析、2022年～2032年
  • 市場セグメンテーション
    • 感染症
    • がん
    • 遺伝性疾患
    • その他

第9章 北米のプラスミドDNA製造市場、2022年～2032年

  • 市場概要
  • プラスミドDNA製造市場：グレード別、2022年～2032年
  • プラスミドDNA製造市場：開発フェーズ別、2022年～2032年
  • プラスミドDNA製造市場：用途別、2022年～2032年
  • プラスミドDNA製造市場：疾患別、2022年～2032年
  • プラスミドDNA製造市場：地域別、2022年～2032年
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第10章 英国と欧州連合のプラスミドDNA製造市場、2022年～2032年

  • 市場概要
  • プラスミドDNA製造市場：グレード別、2022年～2032年
  • プラスミドDNA製造市場：開発フェーズ別、2022年～2032年
  • プラスミドDNA製造市場：用途別、2022年～2032年
  • プラスミドDNA製造市場：疾患別、2022年～2032年
  • プラスミドDNA製造市場：地域別、2022年～2032年
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第11章 アジア太平洋のプラスミドDNA製造市場、2022年～2032年

  • 市場概要
  • プラスミドDNA製造市場：グレード別、2022年～2032年
  • プラスミドDNA製造市場：開発フェーズ別、2022年～2032年
  • プラスミドDNA製造市場：用途別、2022年～2032年
  • プラスミドDNA製造市場：疾患別、2022年～2032年
  • プラスミドDNA製造市場：地域別、2022年～2032年
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋

第12章 ラテンアメリカのプラスミドDNA製造市場、2022年～2032年

  • 市場概要
  • プラスミドDNA製造市場：グレード別、2022年～2032年
  • プラスミドDNA製造市場：開発フェーズ別、2022年～2032年
  • プラスミドDNA製造市場：用途別、2022年～2032年
  • プラスミドDNA製造市場：疾患別、2022年～2032年
  • プラスミドDNA製造市場：地域別、2022年～2032年
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第13章 中東・アフリカのプラスミドDNA製造市場、2022年～2032年

  • 市場概要
  • プラスミドDNA製造市場：グレード別、2022年～2032年
  • プラスミドDNA製造市場：開発フェーズ別、2022年～2032年
  • プラスミドDNA製造市場：用途別、2022年～2032年
  • プラスミドDNA製造市場：疾患別、2022年～2032年
  • プラスミドDNA製造市場：地域別、2022年～2032年
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第14章 企業プロファイル

  • Lonza Group
  • Fujifilm Holdings Corporation
  • Aldevron LLC
  • Charles River Laboratories
  • VGXI Inc.
  • Danaher（Aldevron）
  • Kaneka Corp.
  • Nature Technology
  • Cell and Gene Therapy Catapult
  • Eurofins Genomics
  • Luminous BioSciences LLC
  • Akron Biotech
  • その他の主要企業
図表

List of Tables

  • TABLE 1 Global Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 2 Global Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 3 Global Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 4 Global Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 5 North America Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 6 North America Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 7 North America Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 8 North America Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 9 U.S. Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 10 U.S. Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 11 U.S. Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 12 U.S. Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 13 Canada Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 14 Canada Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 15 Canada Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 16 Canada Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 17 Rest of North America Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 19 Rest of North America Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 20 Rest of North America Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 21 UK and European Union Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 23 UK and European Union Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 24 UK and European Union Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 25 UK Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 26 UK Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 27 UK Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 28 UK Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 29 Germany Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 30 Germany Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 31 Germany Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 32 Germany Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 33 Spain Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 34 Spain Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 35 Spain Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 36 Spain Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 37 Italy Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 38 Italy Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 39 Italy Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 40 Italy Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 41 France Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 42 France Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 43 France Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 44 France Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 45 Rest of Europe Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 47 Rest of Europe Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 48 Rest of Europe Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 49 Asia Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 50 Asia Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 51 Asia Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 52 Asia Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 53 China Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 54 China Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 55 China Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 56 China Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 57 Japan Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 58 Japan Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 59 Japan Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 60 Japan Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 61 India Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 62 India Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 63 India Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 64 India Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 65 Australia Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 66 Australia Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 67 Australia Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 68 Australia Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 69 South Korea Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 70 South Korea Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 71 South Korea Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 72 South Korea Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 73 Latin America Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 74 Latin America Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 75 Latin America Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 76 Latin America Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 77 Brazil Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 78 Brazil Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 79 Brazil Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 80 Brazil Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 81 Mexico Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 82 Mexico Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 83 Mexico Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 84 Mexico Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 85 Rest of Latin America Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 87 Rest of Latin America Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 88 Rest of Latin America Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 89 Middle East and Africa Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 91 Middle East and Africa Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 92 Middle East and Africa Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 93 GCC Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 94 GCC Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 95 GCC Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 96 GCC Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 97 Africa Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 98 Africa Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 99 Africa Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 100 Africa Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Plasmid DNA Manufacturing Market By Grade, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Plasmid DNA Manufacturing Market By Development Phase, 2022-2032, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Plasmid DNA Manufacturing Market By Application, 2022-2032, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Plasmid DNA Manufacturing Market By Disease, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Plasmid DNA Manufacturing Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Plasmid DNA Manufacturing Market: Quality Assurance
  • FIG. 5 Global Plasmid DNA Manufacturing Market, By Grade, 2023
  • FIG. 6 Global Plasmid DNA Manufacturing Market, By Development Phase, 2023
  • FIG. 7 Global Plasmid DNA Manufacturing Market, By Application, 2023
  • FIG. 8 Global Plasmid DNA Manufacturing Market, By Disease, 2023
  • FIG. 9 Global Plasmid DNA Manufacturing Market, By Geography, 2023
  • FIG. 10 Market Geographical Opportunity Matrix - Global Plasmid DNA Manufacturing Market, 2023

FIG. 11Market Positioning of Key Plasmid DNA Manufacturing Market Players, 2023

FIG. 12Global Plasmid DNA Manufacturing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 13 Global Plasmid DNA Manufacturing Market, By Grade, 2023 Vs 2032, %
  • FIG. 14 Global Plasmid DNA Manufacturing Market, By Development Phase, 2023 Vs 2032, %
  • FIG. 15 Global Plasmid DNA Manufacturing Market, By Application, 2023 Vs 2032, %
  • FIG. 16 Global Plasmid DNA Manufacturing Market, By Disease, 2023 Vs 2032, %
  • FIG. 17 U.S. Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 18 Canada Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 19 Rest of North America Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 20 UK Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 21 Germany Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 22 Spain Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 23 Italy Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 24 France Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 25 Rest of Europe Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 26 China Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 27 Japan Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 28 India Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 29 Australia Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 30 South Korea Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 31 Rest of Asia Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 32 Brazil Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 33 Mexico Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 34 Rest of Latin America Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 35 GCC Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 36 Africa Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
  • FIG. 37 Rest of Middle East and Africa Plasmid DNA Manufacturing Market (US$ Million), 2022 - 2032
目次
Product Code: 140088-01-24

The plasmid DNA manufacturing market is characterized by its critical role in the production of plasmid DNA used in various therapeutic applications. The plasmid DNA manufacturing market is expected to grow at a CAGR of 21% during the forecast period of 2024 to 2032. The ongoing drivers and innovative strategies employed by key players are expected to shape the landscape of plasmid DNA manufacturing, contributing to the development of advanced genetic therapies and personalized medicine solutions.

Advancements in Genetic Therapies: Pioneering Innovations in Plasmid DNA Applications

The plasmid DNA manufacturing market is being propelled by continuous advancements in genetic therapies, exemplified by pioneering innovations in plasmid DNA applications. Evidence includes the successful integration of plasmid DNA in cutting-edge gene therapies targeting various genetic disorders and chronic diseases. This driver is underscored by the expanding landscape of gene-based therapeutics, with plasmid DNA serving as a crucial component in developing novel treatments. As evidenced by the growing number of clinical trials and approvals for plasmid DNA-based therapies, this driver is expected to be a primary contributor to the market's growth from 2023 to 2032.

Increasing Investments in Biopharmaceutical R&D: Fueling Demand for High-Quality Plasmid DNA

The plasmid DNA manufacturing market is experiencing robust growth due to increasing investments in biopharmaceutical research and development (R&D). Evidence includes rising funding and collaborations in the biopharmaceutical sector, leading to a surge in demand for high-quality plasmid DNA for pre-clinical and clinical studies. This driver is emphasized by the pivotal role of plasmid DNA in the development of gene therapies, vaccines, and other biopharmaceutical products. As evidenced by the substantial increase in R&D activities and partnerships, the market is poised to benefit significantly from the sustained investment in biopharmaceutical innovations.

Growing Emphasis on Personalized Medicine: Customized Plasmid DNA Solutions for Targeted Therapies

The plasmid DNA manufacturing market is witnessing a paradigm shift driven by the growing emphasis on personalized medicine. Evidence includes the increased focus on tailoring therapeutic interventions to individual patient profiles, necessitating the production of customized plasmid DNA solutions. This driver is highlighted by the expanding applications of plasmid DNA in precision medicine, enabling the development of targeted therapies with enhanced efficacy and safety profiles. As evidenced by the rising interest in personalized medicine approaches, the demand for plasmid DNA manufacturing is expected to surge, catering to the specific requirements of individualized treatment strategies.

Regulatory Challenges and Compliance: Navigating Complex Regulatory Landscape

A significant restraint in the plasmid DNA manufacturing market revolves around regulatory challenges and compliance issues. Evidences include the stringent regulations governing the production and quality control of plasmid DNA for therapeutic use. This restraint is further underscored by the need for manufacturers to navigate a complex regulatory landscape, ensuring adherence to guidelines set by regulatory authorities. The evidence also includes instances where regulatory uncertainties and evolving compliance standards pose challenges to market players, impacting the pace of product development and market penetration. Overcoming this restraint requires a proactive approach to establishing robust quality management systems and staying abreast of evolving regulatory requirements.

By Grade: Plasmid DNA Manufacturing Market Dominates the Market

In 2023, the plasmid DNA manufacturing market demonstrated substantial revenue from the GMP Grade segment, reflecting the demand for plasmid DNA meeting stringent Good Manufacturing Practice standards. Simultaneously, the highest CAGR during the forecast period from 2024 to 2032 was observed in the R&D Grade segment, indicating a robust focus on research activities requiring high-quality plasmid DNA. This nuanced segmentation reflects the diverse applications of plasmid DNA across different grades, each catering to specific industry requirements and quality standards.

By Development Phase: Plasmid DNA Manufacturing Market Dominates the Market

The plasmid DNA manufacturing market showcased noteworthy revenue from the Clinical Therapeutics segment in 2023, emphasizing the pivotal role of plasmid DNA in advancing clinical-stage therapies. Concurrently, the highest CAGR during the forecast period was recorded in the Pre-Clinical Therapeutics segment, signifying a surge in research and development activities. This comprehensive segmentation illustrates the dynamic nature of plasmid DNA applications across different development phases, with each phase contributing uniquely to the market's overall growth.

North America Remains the Global Leader

Geographically, the plasmid DNA manufacturing market exhibited diverse trends in 2023, with North America leading in revenue generation and the highest CAGR. This reflects the region's dominance in biopharmaceutical R&D and its role as a hub for innovative gene therapy initiatives. Europe also contributed significantly to revenue, driven by a robust biotechnology landscape and increasing investments in personalized medicine. Asia-Pacific, while emerging, maintained a steady demand for plasmid DNA manufacturing, fueled by growing collaborations and a rising focus on biopharmaceutical advancements. These geographic trends underscore the global nature of the plasmid DNA manufacturing market, with different regions playing crucial roles in its expansion and evolution.

Market Competition to Intensify during the Forecast Period

In the competitive landscape, top players such as Lonza Group, Fujifilm Holdings Corporation, Aldevron LLC, Charles River Laboratories, VGXI, Inc., Danaher (Aldevron), Kaneka Corp., Nature Technology, Cell and Gene Therapy Catapult, Eurofins Genomics, Luminous BioSciences, LLC and Akron Biotech are shaping the market with their extensive expertise and strategic approaches. These key players reported substantial revenues in 2023, with expectations of continued growth from 2024 to 2032. Their strategic focus on addressing the evolving needs of genetic therapies, expanding production capacities, and ensuring compliance with regulatory standards positions them as influential entities in the plasmid DNA manufacturing landscape. As the market progresses, these players are anticipated to play a pivotal role in advancing technologies and contributing to the seamless production of high-quality plasmid DNA for therapeutic applications.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofPlasmid DNA Manufacturing market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Plasmid DNA Manufacturing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Grade

    • R&D Grade
    • GMP Grade

Development Phase

    • Pre-Clinical Therapeutics
    • Clinical Therapeutics
    • Marketed Therapeutics

Application

    • DNA Vaccines
    • Cell & Gene Therapy
    • Immunotherapy
    • Others

Disease

    • Infectious Disease
    • Cancer
    • Genetic Disorder
    • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Plasmid DNA Manufacturing market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Plasmid DNA Manufacturing market?
  • Which is the largest regional market for Plasmid DNA Manufacturing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Plasmid DNA Manufacturing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Plasmid DNA Manufacturing market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Plasmid DNA Manufacturing Market
  • 2.2. Global Plasmid DNA Manufacturing Market, By Grade, 2023 (US$ Million)
  • 2.3. Global Plasmid DNA Manufacturing Market, By Development Phase, 2023 (US$ Million)
  • 2.4. Global Plasmid DNA Manufacturing Market, By Application, 2023 (US$ Million)
  • 2.5. Global Plasmid DNA Manufacturing Market, By Disease, 2023 (US$ Million)
  • 2.6. Global Plasmid DNA Manufacturing Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Plasmid DNA Manufacturing Market: Competitive Analysis

  • 3.1. Market Positioning of Key Plasmid DNA Manufacturing Market Vendors
  • 3.2. Strategies Adopted by Plasmid DNA Manufacturing Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Plasmid DNA Manufacturing Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Plasmid DNA Manufacturing Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. R&D Grade
    • 5.4.2. GMP Grade

6. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. Pre-Clinical Therapeutics
    • 6.4.2. Clinical Therapeutics
    • 6.4.3. Marketed Therapeutics

7. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Volume and Pricing Analysis, 2022-2032
  • 7.4. Market Segmentation
    • 7.4.1. DNA Vaccines
    • 7.4.2. Cell & Gene Therapy
    • 7.4.3. Immunotherapy
    • 7.4.4. Others

8. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Volume and Pricing Analysis, 2022-2032
  • 8.4. Market Segmentation
    • 8.4.1. Infectious Disease
    • 8.4.2. Cancer
    • 8.4.3. Genetic Disorder
    • 8.4.4. Others

9. North America Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
  • 9.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
  • 9.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
  • 9.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
  • 9.6.Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 9.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 9.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 9.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 9.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 9.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 9.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 9.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 9.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 9.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)

10. UK and European Union Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
  • 10.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
  • 10.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
  • 10.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
  • 10.6.Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 10.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 10.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 10.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 10.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 10.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 10.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 10.6.1.4.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 10.6.1.4.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.4.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 10.6.1.5.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 10.6.1.5.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.5.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 10.6.1.6.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 10.6.1.6.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.6.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)

11. Asia Pacific Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
  • 11.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
  • 11.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
  • 11.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
  • 11.6.Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 11.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 11.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 11.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 11.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 11.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 11.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 11.6.1.4.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 11.6.1.4.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.4.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 11.6.1.5.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 11.6.1.5.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.5.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 11.6.1.6.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 11.6.1.6.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.6.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)

12. Latin America Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
  • 12.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
  • 12.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
  • 12.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
  • 12.6.Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 12.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 12.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 12.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 12.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 12.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 12.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 12.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 12.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 12.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)

13. Middle East and Africa Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
  • 13.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
  • 13.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
  • 13.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
  • 13.6.Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 13.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 13.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 13.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 13.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 13.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 13.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
        • 13.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
        • 13.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
        • 13.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Lonza Group
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Fujifilm Holdings Corporation
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Aldevron LLC
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Charles River Laboratories
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. VGXI, Inc.
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Danaher (Aldevron)
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Kaneka Corp.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Nature Technology
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Cell and Gene Therapy Catapult
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Eurofins Genomics
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Luminous BioSciences, LLC
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Akron Biotech
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Other Notable Players
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives